Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

PLOS ONE logoLink to PLOS ONE
. 2016 Mar 23;11(3):e0152450. doi: 10.1371/journal.pone.0152450

Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

The PLOS ONE Staff
PMCID: PMC4805185  PMID: 27008469

Notice of Republication

The original Supporting Information files were published in error. The files were removed from the HTML and PDF versions of this article on March 11, 2016. The publisher apologizes for the error.

Reference


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES